Screener
Aura Biosciences, Inc. AURA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Aura Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Aura Biosciences, Inc.’s 10-Q, filed May 11, 2026.
- Filed
- May 11, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-216808
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Cash and cash equivalents | $84,793 | $59,515 |
| Marketable securities | 29,940 | 84,726 |
| Prepaid expenses and other current assets | 3,771 | 5,498 |
| Total current assets | 118,504 | 149,739 |
| Restricted cash and deposits | 768 | 768 |
| Right-of-use assets - operating lease | 15,416 | 15,828 |
| Other long-term assets | 517 | 471 |
| Property and equipment, net | 2,472 | 2,624 |
Item 1. Financial Statements.
FAQ
- What is Aura Biosciences, Inc.'s total current assets?
- Aura Biosciences, Inc. (AURA) reported total current assets of $118.5M in Q1 2026.
- How has Aura Biosciences, Inc.'s total current assets changed year-over-year?
- Aura Biosciences, Inc.'s total current assets decreased by 11.9% year-over-year, from $134.52M to $118.5M.
- What is the long-term trend for Aura Biosciences, Inc.'s total current assets?
- Over 5 years (2020 to 2025), Aura Biosciences, Inc.'s total current assets has grown at a 52.0% compound annual growth rate (CAGR), from $18.46M to $149.74M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Aura Biosciences, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude